Lumiracoxib [Prexige] appears to have a significantly less impact on BP than ibuprofen in patients with osteoarthritis who also have controlled hypertension

Author：  

Publisher： Adis International

ISSN： 0114-9954

Source： Reactions Weekly, Vol.1, Iss.1157, 2007-01, pp. : 4-4

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Lumiracoxib: less gastroduodenal toxicity than ibuprofen

By  

Reactions Weekly, Vol. 1, Iss. 1010, 2004-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

Oral fluconazole appears to have a greater impact than IV fluconazole on the interaction with calcineurin inhibitors that are given by continuous IV infusion

By  

Reactions Weekly, Vol. 1, Iss. 1192, 2008-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Since Novartis' COX-2 inhibitor lumiracoxib [`Prexige'] has failed to demonstrate features differentiating it from the class leader celecoxib [`Celebrex; Pfizer/Pharmacia'], it could have limited market success

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 403, 2003-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite

The risk of developing type 2 diabetes mellitus (DM) appears to be significantly less among olanzapine recipients than clozapine recipients

By  

Reactions Weekly, Vol. 1, Iss. 1208, 2008-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Schizophrenic patients who smoke have a faster finger tapping rate than non-smokers

By Silver H.   Shlomo N.   Hiemke C.   Rao M.-L.   Ritsner M.   Modai I.  

European Neuropsychopharmacology, Vol. 12, Iss. 2, 2002-04 ,pp. : 141-144

Elsevier

Access to resources Recommend Favorite